Forte Biosciences Inc. (NASDAQ:FBRX) shares are trading higher Wednesday. The company announced a $53 million private placement to fund the development of its autoimmune-focused drug candidate, FB102.
Forte is finally getting a crack at running in a Triple Crown race. The colt, who was scratched the day of the Kentucky Derby, is the early favorite for the Belmont Stakes. Forte, last year's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback